Menus Subscribe Search

Follow us


Someone Else Owns Your Genes

• May 14, 2013 • 6:00 AM

How it happened, why it matters now, and why it won’t be a big deal in the future.

On April 15, in the case of The Association for Molecular Pathology vs. Myriad Genetics, Inc., the United States Supreme Court heard arguments questioning the legitimacy of patents on human genes. A genetic testing company, Myriad Genetics, has patent claims on two human genes that influence a person’s risk for breast cancer. Myriad is being sued by a conglomerate of physicians, scientists, and patients who argue that Myriad has illegitimately patented a product of nature. While the lawyers and Justices delved into the arcana of patent law and molecular biology, many of the rest of us were wondering: how the heck can you patent someone’s genes?

The idea of having your genome Balkanized into small fiefdoms of intellectual property may sound offensive, but do gene patents make any practical difference?

Well, genetic information, much like a text, is encoded as a sequence of chemical “letters.” The alphabet of DNA consists of four letters (whose chemical names are abbreviated as A, C, T, or G), and each gene is made up of a sequence of tens of thousands of these letters. Scientists read the text of a gene by “sequencing” it: determining its sequence of letters. Knowing the sequence of a gene is not just important to scientists who study how that gene works; the sequence is also important for patients who are worried about their genetic risk for certain diseases. Each of us has small misspellings, deletions, and insertions scattered all over our genetic text—it’s what makes us unique from one another—and while most of these mutations are harmless, some are dangerous. For example, the information in the sequence of your particular copy of the gene BRCA1 can tell you whether you are at high risk for breast cancer. By sequencing the BRCA1 gene, you (or your mother, wife, or daughter) can find out whether you have a high-risk version of BRCA1—as long as you pay Myriad Genetics to read your sequence, because Myriad owns a patent on the sequence of your BRCA1 gene.

How did Myriad Genetics get a patent on the naturally occurring DNA sequence of the BRCA1 gene of every man, woman, and child in America? (They also own a patent on the sequence of BRCA2, another breast cancer risk gene.) Here’s the trick: you can own the naturally occurring sequence of a gene by making a patent claim to all physical copies of that sequence that exist outside of human cells.

This trick works because, in the process of sequencing a gene, scientists create a synthetic copy. This synthetic copy is chemically the same as the original; it has the exact same sequence of chemical letters that was put together by nature inside your cells. Synthetic copies of genes are routinely created in the lab using very general methods widely used by molecular biologists for decades, methods that were not invented by Myriad Genetics. However, Myriad was first to sequence the BRCA1 gene, and they claimed physical copies of the BRCA1 sequence as their original invention. The result is that nobody can read the sequence of any BRCA1 gene of anyone in America without Myriad’s permission.

THE IDEA OF HAVING your genome Balkanized into small fiefdoms of intellectual property may sound offensive, but do gene patents make any practical difference? Yes and no. If you are worried about your genetic risk for breast cancer and Myriad doesn’t take your insurance, you’re out of luck. Want a second opinion on Myriad’s interpretation of your genetic risk? Nobody is legally allowed to offer one. Aggressively protected gene patents also interfere with basic research focused on studying how genes function and contribute to disease, because they prevent scientists from using basic research tools to study those genes.

(What’s the point of a gene patent, then? Money. Your BRCA1 sequence is important to you, and Myriad wants you to pay them, and only them, for it.)

On the other hand, the era of human gene patents appears to be ending, regardless of what the Supreme Court decides. Myriad Genetics obtained its gene patents at a time when sequencing one gene was a big job; with the same effort today, we can sequence thousands of genes at once. A company that offers to predict your genetic risk for disease by reading only a single gene is going to look shabby compared to competitors that offer to sequence a large fraction of your genome to give you a much more comprehensive estimate of your genetic risk. Gene patents may hold off the competition for a limited time (while also temporarily holding up some basic genetics research and causing anxiety and suffering among patients), but they won’t stop the arrival of a new standard of genetic testing based on low-cost readings of all your genes.

Michael White
Michael White is a systems biologist at the Department of Genetics and the Center for Genome Sciences and Systems Biology at the Washington University School of Medicine in St. Louis, where he studies how DNA encodes information for gene regulation. He co-founded the online science pub The Finch and Pea. Follow him on Twitter @genologos.

More From Michael White

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

October 22 • 4:00 PM

The Last Thing the Women’s Movement Needs Is a Heroic Male Takeover

Is the United Nations’ #HeForShe campaign helping feminism?


October 22 • 2:00 PM

Turning Public Education Into Private Profits

Baker Mitchell is a politically connected North Carolina businessman who celebrates the power of the free market. Every year, millions of public education dollars flow through Mitchell’s chain of four non-profit charter schools to for-profit companies he controls.


October 22 • 12:00 PM

Will the End of a Tax Loophole Kill Off Irish Business and Force Google and Apple to Pay Up?

U.S. technology giants have constructed international offices in Dublin in order to take advantage of favorable tax policies that are now changing. But Ireland might have enough other draws to keep them there even when costs climb.


October 22 • 10:00 AM

Veterans in the Ivory Tower

Why there aren’t enough veterans at America’s top schools—and what some people are trying to do to change that.


October 22 • 8:00 AM

Our Language Prejudices Don’t Make No Sense

We should embrace the fact that there’s no single recipe for English. Making fun of people for replacing “ask” with “aks,” or for frequently using double negatives just makes you look like the unsophisticated one.


October 22 • 7:04 AM

My Politicians Are Better Looking Than Yours

A new study finds we judge the cover by the book—or at least the party.


October 22 • 6:00 AM

How We Form Our Routines

Whether it’s a morning cup of coffee or a glass of warm milk before bed, we all have our habitual processions. The way they become engrained, though, varies from person to person.


October 22 • 4:00 AM

For Preschoolers, Spite and Smarts Go Together

New research from Germany finds greater cognitive skills are associated with more spiteful behavior in children.


October 21 • 4:00 PM

Why the Number of Reported Sexual Offenses Is Skyrocketing at Occidental College

When you make it easier to report assault, people will come forward.


October 21 • 2:00 PM

Private Donors Are Supplying Spy Gear to Cops Across the Country Without Any Oversight

There’s little public scrutiny when private donors pay to give police controversial technology and weapons. Sometimes, companies are donors to the same foundations that purchase their products for police.


October 21 • 12:00 PM

How Clever Do You Think Your Dog Is?

Maybe as smart as a four-year-old child?


October 21 • 10:00 AM

Converting the Climate Change Non-Believers

When hard science isn’t enough, what can be done?



October 21 • 8:00 AM

Education Policy Is Stuck in the Manufacturing Age

Refining our policies and teaching social and emotional skills will help us to generate sustained prosperity.


October 21 • 7:13 AM

That Cigarette Would Make a Great Water Filter

Clean out the ashtray, add some aluminum oxide, and you’ve (almost) got yourself a low-cost way to remove arsenic from drinking water.


October 21 • 6:00 AM

Fruits and Vegetables Are About to Enter a Flavor Renaissance

Chefs are teaming up with plant breeders to revitalize bland produce with robust flavors and exotic beauty—qualities long neglected by industrial agriculture.


October 21 • 4:00 AM

She’s Cheating on Him, You Can Tell Just by Watching Them

New research suggests telltale signs of infidelity emerge even in a three- to five-minute video.


October 21 • 2:00 AM

Cheating Demographic Doom: Pittsburgh Exceptionalism and Japan’s Surprising Economic Resilience

Don’t judge a metro or a nation-state by its population numbers.


October 20 • 4:00 PM

The Bird Hat Craze That Sparked a Preservation Movement

How a fashion statement at the turn of the 19th century led to the creation of the first Audubon societies.


October 20 • 2:00 PM

The Risk of Getting Killed by the Police If You Are White, and If You Are Black

An analysis of killings by police shows outsize risk for young black males.


October 20 • 12:00 PM

Love and Hate in Israel and Palestine

Psychologists find that parties to a conflict think they’re motivated by love while their enemies are motivated by hate.


October 20 • 11:00 AM

My Dog Comes First: The Importance of Pets to Homeless Youth

Dogs and cats have both advantages and disadvantages for street-involved youth.


October 20 • 10:00 AM

Homophobia Is Not a Thing of the Past

Despite growing support for LGBT rights and recent decisions from the Supreme Court regarding the legality of same-sex marriage, the battle for acceptance has not yet been decided.


October 20 • 8:00 AM

Big Boobs Matter Most

Medical mnemonics are often scandalous and sexist, but they help the student to both remember important facts and cope with challenging new experiences.


October 20 • 6:00 AM

When Disease Becomes Political: The Likely Electoral Fallout From Ebola

Will voters blame President Obama—and punish Democrats in the upcoming mid-term elections—for a climate of fear?


Follow us


My Politicians Are Better Looking Than Yours

A new study finds we judge the cover by the book—or at least the party.

That Cigarette Would Make a Great Water Filter

Clean out the ashtray, add some aluminum oxide, and you've (almost) got yourself a low-cost way to remove arsenic from drinking water.

Love and Hate in Israel and Palestine

Psychologists find that parties to a conflict think they're motivated by love while their enemies are motivated by hate.

How to Water a Farm in Sandy Ground

Physicists investigate how to grow food more efficiently in fine-grained soil.

Unlocking Consciousness

A study of vegetative patients closes in on the nature of consciousness.

The Big One

One company, Amazon, controls 67 percent of the e-book market in the United States—down from 90 percent five years ago. September/October 2014 new-big-one-5

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.